Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

413 Press Releases
DateTitleCompany
24 Jun 16 Teva Receives CHMP Positive Opinion for CINQAERO® (reslizumab) Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Jun 16 Teva Settles Patent Litigation with AstraZeneca Allowing Teva to Commercialize Its Generic Version of Byetta® (Exenatide Injection) in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
20 Jun 16 Teva to Present Data Highlighting SD-809 at 20th International Congress of Parkinson’s Disease and Movement Disorders Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
13 Jun 16 Teva Announces Voluntary Suspension of Marketing for ZECUITY® in the U.S. Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Jun 16 Teva Announces Favorable Court Ruling in TREANDA® (bendamustine hydrochloride) Patent Infringement Litigation Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Jun 16 Teva Gains Recommendation for Approval from FDA Advisory Committees for VANTRELA™ ER (hydrocodone bitartrate) Extended-Release Tablets CII Formulated with Proprietary Abuse Deterrence Technology Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
31 May 16 Teva to Present at the Bernstein 32nd Annual Strategic Decisions Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
31 May 16 Teva Receives Complete Response Letter for NDA for SD-809 for the Treatment of Chorea Associated with Huntington Disease Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
09 May 16 Teva to Present at the Bank of America Merrill Lynch 2016 Health Care Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
29 Apr 16 Teva Announces FDA Approval of ProAir RespiClick® (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4 to 11 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Apr 16 Jennifer Morrison Reveals How Her Journey with Migraine is More Than a Headache Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Apr 16 Teva to Present Data Highlighting Company’s Pipeline in Neurological Disorders at 68th AAN Annual Meeting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Mar 16 Teva Announces FDA Approval of CINQAIR® (reslizumab) Injection Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
22 Mar 16 Teva Announces Launch of Generic Campral® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Mar 16 Teva Receives European Commission Approval for the Allergan Generics Acquisition Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
09 Mar 16 Teva Completes Generic Pulmicort® Respules Portfolio with the Launch of Third Strength in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Mar 16 Teva Completes Acquisition of Rimsa Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Mar 16 Teva to Present New Respiratory Data at the 2016 Academy of Allergy, Asthma and Immunology Annual Meeting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Dec 15 Takeda Provides Further Information about its New Business Venture with Teva Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
04 Jan 16 Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Jan 16 Teva Announces Launch of Generic Ortho Tri-Cyclen® Lo in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Jan 16 Teva and Checkpoint Therapeutics Announce License Agreement for Oral PARP Inhibitor Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
11 Feb 16 Teva Files 2015 Annual Report on Form 20-F Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Dec 15 INSERTING and REPLACING Takeda Provides Further Information about its New Business Venture with Teva Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Jan 16 Teva to Present at the 34th Annual J.P. Morgan Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
24 Feb 16 Teva Pharmaceuticals Embarks on Strategic Corporate Identity Program to Build a Global Brand Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Jan 16 Teva to Report Fourth Quarter 2015 Financial Results on February 11, 2016 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Jan 16 Teva Announces Exercise of Underwriters’ Over-Allotment Option Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Jan 16 Teva Releases Innovation and Social Responsibility Highlights Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Feb 16 Teva and AbCellera Enter Into Agreement to Discover Rare Monoclonal Antibodies Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.